Related Experiment Video

Updated: Oct 19, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

955

Health expenditures of asthma-COPD overlap in Northern Jordan

Shoroq M Altawalbeh1, Bushra Hijazi1, Lara Kufoof2

  • 1Department of Clinical Pharmacy, School of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Plos One
|September 21, 2021
PubMed

Insights

Patients with Asthma-COPD overlap (ACO) incur significantly higher respiratory and overall medical costs compared to those with asthma or COPD alone. This highlights ACO as a major driver of healthcare expenditure.

Area of Science:

  • Respiratory Medicine
  • Health Economics
  • Clinical Epidemiology

Background:

  • Asthma-COPD overlap (ACO) presents a complex clinical and economic challenge.
  • Understanding the healthcare expenditure associated with ACO is crucial for resource allocation.

Purpose of the Study:

  • To compare the medical expenditures of patients with ACO against those with asthma or COPD.
  • To identify predictors of higher healthcare costs in ACO patients.

Main Methods:

  • Retrospective cohort study of patients diagnosed with ACO, asthma, or COPD.
  • Analysis of medical records and billing data from King Abdullah University Hospital, Jordan (2015-2016).
  • Comparison of respiratory and all-cause charges across the three disease groups.

Main Results:

  • ACO patients incurred significantly higher average respiratory charges (601.4 JOD) than asthma patients (354.3 JOD).
  • All-cause charges were higher for ACO (1830.8 JOD) and COPD (1705.4 JOD) compared to asthma (1251.7 JOD).
  • ACO was a significant predictor of increased respiratory and all-cause expenditures; older age and higher disease severity also correlated with higher respiratory costs.

Conclusions:

  • Asthma-COPD overlap (ACO) is a significant risk factor for elevated healthcare expenditures in Jordan.
  • Higher respiratory costs are associated with advanced age and greater disease severity in respiratory patients.
Abstract

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

998

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
478
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
836
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K